Pharmacokinetics-Based Adjusted Versus Standard Dose of Ribavirin Does Not Improve Virologic Response Rates in Chronic Hepatitis C Genotype 4 Patients: A Randomized Controlled Trial-Reference-Cited by-同舟云学术

Pharmacokinetics-Based Adjusted Versus Standard Dose of Ribavirin Does Not Improve Virologic Response Rates in Chronic Hepatitis C Genotype 4 Patients: A Randomized Controlled Trial

Published:2017-11 Issue:11 Volume:37 Page:488-493
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Altraif Ibrahim H.¹,Sanai Faisal²,Babatin Mohammed A.³,Alalwan Abduljaleel A.¹,Abdo Ayman A.⁴,Alhamoudi Waleed⁴,Peedikayil Musthafa⁵,Alghamdi Hamdan¹,Alsohaibani Fahad⁵,Alswat Khalid A.⁴,Murtaza Shazia¹,Alghamdi Abdullah³,Altraif Sara¹,Aljumah Abdulrahman¹,Handoo Fayaz A.¹,AlBekairy Abdulkareem M.⁶,Al-ashgar Hamad I.⁷,Alquaiz Mohammed⁵,Alblawi Mohammed A.⁸,AlTamimi Waleed⁸,Loustaud-Ratti Véronique⁹,Marquett Pierre¹⁰

Affiliation:

1. Division of Hepatology, Department of Organ Transplant and Hepatobiliary Sciences, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center/King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

2. Gastroenterology Unit, Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.

3. Gastroenterology Unit, Department of Medicine, King Fahad General Hospital, Jeddah, Saudi Arabia.

4. Liver Disease Research Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

5. Gastroenterology Section, Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

6. Department of Pharmaceutical Care, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center/King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

7. Gastroenterology Section, Department of Medicine, King Faisal Specialist Hospital and Research Center, Alfaisal University, Riyadh, Saudi Arabia.

8. Department of Pathology and Laboratory Medicine, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center/King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

9. Department of Hepatogastroenterology, CHU Limoges, Univ Limoges, Limoges, France.

10. Department of Pharmacology and Toxicology, CHU Limoges, Limoges, France.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jir.2017.0054

Reference24 articles.

1. Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift

2. Sustained virologic response to peginterferon α-2a and ribavirin in 335 patients with chronic hepatitis C: A tertiary care center experience

3. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4

4. HCV genotypes among 1013 Saudi nationals: a multicenter study